Proteins are vital building blocks for biological systems, and they have a wide range of applications in biochemical research, industrial catalyzation, food processing, vaccine development, and therapeutics. However, obtaining sufficient quantities of proteins can be challenging, especially for large-scale industrial and drug manufacturing applications. Recombinant protein production is the best solution for this problem, since it can be used to produce proteins in a controlled manner with high purity and consistency.

This is recombinant protein service by cloning the target gene into an expression vector and then transfecting this vector into suitable host cells. Yeast, bacteria, and mammalian cells can all be used as host organisms, but each has its own advantages. For example, bacterial systems excel in producing small, soluble proteins, while mammalian cells such as Chinese hamster ovary (CHO) cells are better suited for complex post-translational modifications and secretion.

ELISA Test vs. Western Blot: Key Differences and Applications

Recombinant proteins can be produced rapidly, making them ideal for applications that require quick response times such as diagnostics and therapies. Additionally, they can be manipulated to include functional motifs that may not be present in native proteins or natural antibodies. This allows researchers to create a protein with a specific set of properties that are not naturally available, such as elevated hydrophobicity or disordered regions.

Sino Biological provides comprehensive recombinant protein service, including gene cloning, synthesis, and characterization. We also offer expert services for expression optimization in bacterial, baculovirus/insect, and mammalian systems. We use advanced tools such as GenSmart codon optimization and our TurboCHO high-throughput platform to deliver high-quality, stable recombinant proteins with minimal time investment.